Voyager Therapeutics (MEX:VYGR) Cyclically Adjusted FCF per Share: MXN-19.73 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:VYGR Voyager Therapeutics Inc MEX:VYGR
54 GF Score
Price MXN63.00
GF Value MXN35.07
! 4 Warning Signs
View Full Analysis

What is Voyager Therapeutics Cyclically Adjusted FCF per Share?

Voyager Therapeutics MEX:VYGR 54 Cyclically Adjusted FCF per Share is MXN-19.73 as of Mar. 2026. GuruFocus rates MEX:VYGR with a GF Score™ of 54/100 and a GF Value™ of MXN35.07. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Voyager Therapeutics's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN-10.133. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN-19.73 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-30), Voyager Therapeutics's current stock price is MXN63.00. Voyager Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN-19.73. Voyager Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Voyager Therapeutics  (MEX:VYGR) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Voyager Therapeutics Cyclically Adjusted FCF per Share Related Terms


Voyager Therapeutics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Voyager Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyager Therapeutics Cyclically Adjusted FCF per Share Chart

Voyager Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -11.93 -19.87

Voyager Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -52.72 -22.61 -16.72 -19.87 -19.73

MEX:VYGR vs NERV, DTIL, GLSI: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Voyager Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Voyager Therapeutics Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Voyager Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Voyager Therapeutics's Cyclically Adjusted Price-to-FCF falls into.


MEX:VYGR
54GF Score
Voyager Therapeutics Inc MEX:VYGR
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyager Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Voyager Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-10.133/330.2130*330.2130
=-10.133

Current CPI (Mar. 2026) = 330.2130.

Voyager Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -7.265 241.018 -9.954
201609 -8.148 241.428 -11.144
201612 -13.698 241.432 -18.735
201703 -12.585 243.801 -17.046
201706 -11.706 244.955 -15.780
201709 -11.305 246.819 -15.125
201712 -10.048 246.524 -13.459
201803 26.887 249.554 35.577
201806 -14.642 251.989 -19.187
201809 -10.747 252.439 -14.058
201812 -15.105 251.233 -19.854
201903 72.152 254.202 93.727
201906 -17.022 256.143 -21.944
201909 -12.225 256.759 -15.722
201912 -13.684 256.974 -17.584
202003 -19.224 258.115 -24.594
202006 -14.388 257.797 -18.430
202009 -17.529 260.280 -22.239
202012 -13.620 260.474 -17.267
202103 -11.811 264.877 -14.724
202106 -12.153 271.696 -14.770
202109 -11.630 274.310 -14.000
202112 5.886 278.802 6.971
202203 17.995 287.504 20.668
202206 -10.363 296.311 -11.549
202209 -8.379 296.808 -9.322
202212 -6.664 296.797 -7.414
202303 52.610 301.836 57.556
202306 -0.806 305.109 -0.872
202309 -8.670 307.789 -9.302
202312 -8.249 306.746 -8.880
202403 16.454 312.332 17.396
202406 -10.330 314.175 -10.857
202409 -9.607 315.301 -10.061
202412 -5.282 315.605 -5.526
202503 -13.517 319.799 -13.957
202506 -11.030 322.561 -11.292
202509 -9.750 324.800 -9.912
202512 -9.436 324.054 -9.615
202603 -10.133 330.213 -10.133

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN-19.73 mean?
Voyager Therapeutics (MEX:VYGR) has a Cyclically Adjusted FCF per Share of MXN-19.73 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Voyager Therapeutics and its competitors.
Is Voyager Therapeutics' Cyclically Adjusted FCF per Share too high?
Voyager Therapeutics' current Cyclically Adjusted FCF per Share is MXN-19.73. Overall, Voyager Therapeutics has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Voyager Therapeutics' Cyclically Adjusted FCF per Share compare to NERV and DTIL?
Voyager Therapeutics' Cyclically Adjusted FCF per Share of MXN-19.73 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Voyager Therapeutics and its competitors. Voyager Therapeutics's current Cyclically Adjusted FCF per Share is MXN-19.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyager Therapeutics stock overvalued right now?
Voyager Therapeutics (MEX:VYGR) has a current Cyclically Adjusted FCF per Share of MXN-19.73. The stock's GF Value™ is MXN35.07, compared to a current price of MXN63.00 — trading 79.6% above its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN-19.73. Voyager Therapeutics' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Voyager Therapeutics (MEX:VYGR), the current Cyclically Adjusted FCF per Share is MXN-19.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Voyager Therapeutics (MEX:VYGR) Overvalued in 2026?

Based on GuruFocus' analysis, Voyager Therapeutics stock appears to be overvalued. The current stock price of MXN63.00 is trading 79.6% above its estimated GF Value™ of MXN35.07.

Key valuation signals for MEX:VYGR:

  • Cyclically Adjusted FCF per Share: MXN-19.73
  • GF Value™: MXN35.07 vs. price of MXN63.00 (79.6% above fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the MEX:VYGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Voyager Therapeutics Business Description

Other Exchanges VYGR:USAVT6:Germany
Address 75 Hayden Avenue, Lexington, MA, USA, 02421
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
54GF Score

Get the complete analysis for MEX:VYGR

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN63.00
Price
MXN35.07
GF Value